Robin L. Fisher

Improvement in Lipoatrophy Associated with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Patients Switched from Stavudine to Abacavir or Zidovudine: The Results of the TARHEEL Study

Grace A. McComsey, Douglas Ward, Siegrid M. Hessenthaler et al. · Clinical Infectious Diseases · 2004 · 187 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

Grace A. McComsey, D. Paulsen, J Tyler Lonergan et al. · AIDS · 2004 · 171 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection

Joseph J. Eron, Ellen S. Yetzer, Peter Ruane et al. · AIDS · 2000 · 62 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome

Ralph DeMasi, Neil M.H. Graham, Jerry M. Tolson et al. · Advances in Therapy · 2001 · 54 citations

Public Health, Pharmacotherapy, Hiv Control +14

Twice‐Daily Triple Nucleoside Intensification Treatment with Lamivudine‐Zidovudine plus Abacavir Sustains Suppression of Human Immunodeficiency Virus Type 1: Results of the TARGET Study

Keith Henry, Robert Wallace, Paul C. Bellman et al. · The Journal of Infectious Diseases · 2001 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +17